| value |
{"aggregator_url":"https://news.google {"aggregator_url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxObmtkMExEMGwzLWo3NllPMlhodHBXYVlYRU1aRXhmd2FNTWo1dXI3SmVzZzNJVWJ1VEhXSExZYU00aHVmenZ2bmpOa0lDMmhTa083ZWRvbGlNZ2xobWtwdkxlX292cGU5Rzh5NV9odUhLdGZsRl81RVVGNmcta2VWek5VNzM5a2xsYlQxTk14RnJKcVRFY1JYQXRaLXZaUmM?oc=5","as_of":"2026-04-09T12:01:20.918169+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxObmtkMExEMGwzLWo3NllPMlhodHBXYVlYRU1aRXhmd2FNTWo1dXI3SmVzZzNJVWJ1VEhXSExZYU00aHVmenZ2bmpOa0lDMmhTa083ZWRvbGlNZ2xobWtwdkxlX292cGU5Rzh5NV9odUhLdGZsRl81RVVGNmcta2VWek5VNzM5a2xsYlQxTk14RnJKcVRFY1JYQXRaLXZaUmM?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_48365901bfd880ef","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-09T23:16:51.609725+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxObmtkMExEMGwzLWo3NllPMlhodHBXYVlYRU1aRXhmd2FNTWo1dXI3SmVzZzNJVWJ1VEhXSExZYU00aHVmenZ2bmpOa0lDMmhTa083ZWRvbGlNZ2xobWtwdkxlX292cGU5Rzh5NV9odUhLdGZsRl81RVVGNmcta2VWek5VNzM5a2xsYlQxTk14RnJKcVRFY1JYQXRaLXZaUmM?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"finance.yahoo.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxObmtkMExEMGwzLWo3NllPMlhodHBXYVlYRU1aRXhmd2FNTWo1dXI3SmVzZzNJVWJ1VEhXSExZYU00aHVmenZ2bmpOa0lDMmhTa083ZWRvbGlNZ2xobWtwdkxlX292cGU5Rzh5NV9odUhLdGZsRl81RVVGNmcta2VWek5VNzM5a2xsYlQxTk14RnJKcVRFY1JYQXRaLXZaUmM?oc=5","source_event_id":"evt_d1bd6ab8a38e","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"d91999de136b3cd5","published_at":"2026-04-09T11:41:47+00:00","publisher_domain":"finance.yahoo.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.7,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Pfizer","relevance":"primary focus of the headline comparison","symbol":"PFE","type":"company"},{"asset_class":"equity_group","name":"Branded Pharmaceuticals stocks","relevance":"peer set referenced in the headline","symbol":"","type":"sector_group"},{"asset_class":"media","name":"Yahoo Finance","relevance":"source of the article","symbol":"","type":"publisher"}],"event_type":"earnings","information_gaps":["The cleaned article text provided contains only page styling/HTML fragments and does not include the actual article content.","No Q4 earnings numbers (revenue, EPS, guidance), surprise amounts, or whether Pfizer\u2019s performance was positive/negative are included in the provided text.","No list of \u201cthe rest of the branded pharmaceuticals stocks\u201d (peer tickers/companies) is included.","No timing details (exact earnings release date, publication date, or market reaction window) are included."],"key_facts":["Headline indicates an article comparing Pfizer (NYSE:PFE) Q4 earnings highs and lows versus other branded pharmaceuticals stocks.","No specific Q4 metrics, dates, or named peer companies are present in the provided cleaned text."],"numeric_claims":[],"primary_claim":"Yahoo Finance published a piece titled \u201cQ4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks,\u201d comparing Pfizer\u2019s Q4 earnings outcomes to other branded pharma stocks.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"The Yahoo Finance article compares Pfizer\u2019s Q4 earnings performance (highs and lows) against other branded pharmaceuticals stocks. The provided text includes only the headline and a duplicate source summary, with no underlying earnings figures or specific peer comparisons.","topics":["Q4 earnings","Pfizer","branded pharmaceuticals","stock performance comparison"]},"source":"Yahoo Finance","source_domain":"finance.yahoo.com","source_url":"https://finance.yahoo.com","summary":"Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks Yahoo Finance","title":"Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks - Yahoo Finance","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}... |